Add to ORKGTreatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning the new pegylated interferons. As there has been much controversy about the best parameters to determine whether treatment is effective, we analyzed several criteria currently used for evaluation, including serum alanine aminotransferase (ALT) normalization, viral load reduction and improvement of hepatic histology
<p>Abbreviations: ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; N.D., not determi...
Chronic infection with the hepatitis B and C virus represents a major health problem worldwide, as i...
Purpose: Monitoring of hepatitis C virus (HCV) treatment response is performed by serial HCV RNA mea...
Treatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning ...
The current treatment of chronic hepatitis C is based on pegylated alpha interferon (PEG-IFN-) and r...
Hepatitis C virus chronic infection is currently the most common cause of end-stage liver disease. T...
It is not clear what proportion of HCV (hepatitis C virus) patients attain a sustained viral respons...
In chronic hepatitis C (HCV) infection, treatment with interferon is associated with a rather low ra...
The antiviral and immunomodulatory effects of interferon were assessed in the treatment of chronic H...
Hepatitis C virus chronic infection is currently the most common cause of end-stage liver disease. T...
Background: To determine the value of extent of liver injury as a baseline predictor of response to ...
Background : Management of Hepatitis C virus (HCV) infection has been evolved in the last few years...
Treatment of hepatitis C virus infection is currently based on a combination of pegylated interferon...
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepa...
Interferon alpha (IFN-alpha) therapy is currently the treatment of choice for chronic hepatitis C (H...
<p>Abbreviations: ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; N.D., not determi...
Chronic infection with the hepatitis B and C virus represents a major health problem worldwide, as i...
Purpose: Monitoring of hepatitis C virus (HCV) treatment response is performed by serial HCV RNA mea...
Treatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning ...
The current treatment of chronic hepatitis C is based on pegylated alpha interferon (PEG-IFN-) and r...
Hepatitis C virus chronic infection is currently the most common cause of end-stage liver disease. T...
It is not clear what proportion of HCV (hepatitis C virus) patients attain a sustained viral respons...
In chronic hepatitis C (HCV) infection, treatment with interferon is associated with a rather low ra...
The antiviral and immunomodulatory effects of interferon were assessed in the treatment of chronic H...
Hepatitis C virus chronic infection is currently the most common cause of end-stage liver disease. T...
Background: To determine the value of extent of liver injury as a baseline predictor of response to ...
Background : Management of Hepatitis C virus (HCV) infection has been evolved in the last few years...
Treatment of hepatitis C virus infection is currently based on a combination of pegylated interferon...
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepa...
Interferon alpha (IFN-alpha) therapy is currently the treatment of choice for chronic hepatitis C (H...
<p>Abbreviations: ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; N.D., not determi...
Chronic infection with the hepatitis B and C virus represents a major health problem worldwide, as i...
Purpose: Monitoring of hepatitis C virus (HCV) treatment response is performed by serial HCV RNA mea...